Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

BioNTech Stock Recently Got Downgraded. But Is Wall Street Underestimating Its Cancer Pipeline?

Investors buying this biotech stock now will get its pipeline essentially for free.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at fool.com →

More in Finance & Markets

More from Tuesday 22 September →